Particulars |
|
|
|
Company Name
| Glaxosmithkline Pharmaceuticals Ltd
| Year End
| 202503
|
Full Year |
Equity (₹ Cr.) |
169.41 |
B.V. (₹) |
115.10 |
Sales(₹ Cr.) |
3,723.49 |
NP (₹ Cr.) |
865.43 |
NP Var (%) |
33.00 |
Div% |
540.00 |
CPS(₹) |
55.00 |
EPS (₹) |
51.10 |
Traded Value(₹ Lakhs) |
227.99 |
52 Week High |
3,516.00 |
52 Week Low |
1,924.00 |
Price BSE |
3,458.00 |
Price NSE |
3,440.00 |
Market Capital (₹ Cr.) |
58,575.52 |
P/C Ratio |
62.80 |
P/E Ratio |
67.70 |
Price Vs.BV |
30.04 |
|
Latest Quarter |
Year End |
202503 |
Sales (₹ Cr.) |
966.08 |
NP(₹ Cr.) |
260.14 |
NP Var % |
36.00 |
Trailing Twelve Months |
Year End |
202503 |
Sales |
3,526.90 |
OPM |
-5.85 |
NP |
795.84 |
NP Var (%) |
32.88 |
EPS |
51.09 |
PE |
67.68 |
|
|